PDM-631
PDM-631 is a selective and orally active PDE2A inhibitor with blood-brain barrier penetration. PDM-631 exhibits potent inhibitory activity against human and rat recombinant PDE2A with IC50 values of 1.5 nM and 4.2 nM, respectively. PDM-631 increases cGMP levels in the rat cerebral cortex. PDM-631 can be used for the study of schizophrenia and neurodegenerative disorders.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2095312-08-4
- Fòrmula: C19H19F3N4O2
- Peso molecular:392.37
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Actividad biológica
|
PDE2A 1.5 nM (IC50, human) |
PDE2A 4.2 nM (IC50, rat) |
Chemical Information
-
No. CAS 2095312-08-4
-
Peso molecular 392.37
-
Fòrmula C19H19F3N4O2
-
SMILES
FC(F)(F)OC(C=C1)=CC=C1C[C@@H](N2C3=C(C(N=C(N3)C)=O)C(C4CC4)=N2)C
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
PDM-631 Related Classifications
HY-102043 Related Classifications
Powered by Bioz